FDA Approves XARELTO — Janssen Pharmaceuticals, Inc.
# FDA Approves Janssen Pharmaceuticals' XARELTO (Rivaroxaban) Oral Anticoagulant Janssen Pharmaceuticals, Inc. received FDA approval for XARELTO (rivaroxaban), an oral anticoagula…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves Janssen Pharmaceuticals' XARELTO (Rivaroxaban) Oral Anticoagulant Janssen Pharmaceuticals, Inc. received FDA approval for XARELTO (rivaroxaban), an oral anticoagula…
The FDA’s approval of a generic pharmaceutical from SANDOZ is poised to strengthen the company’s market presence and drive revenue growth, however, the specific therapeutics involv…
On March 22, 2011, Actavis Labs Fl Inc received FDA approval for ANDA090084, a generic drug anticipated to drive incremental sales in the specific therapeutic market while offering…
# FDA Approves Bayer's Gadavist (Gadobutrol) for MRI Contrast Imaging Bayer HealthCare Pharmaceuticals Inc. received FDA approval for Gadavist (gadobutrol), an intravenous contras…
Teva Pharmaceutical Industries received FDA approval on Thursday for Nifedipine Extended Release Tablets, extending its reach within the cardiovascular generic market.
SpecGx LLC announced the FDA approval of the Fentanyl Transdermal ANDA (App # ANDA077154) on February 9th, potentially expanding generic competition for the potent opioid pain patc…
Senores Pharma has secured FDA approval for its Abbreviated New Drug Application (ANDA090404), a pivotal development expected to bolster the company's commercial prospects and driv…
# FDA Approves GE Healthcare's DaTscan for Parkinson's Disease Diagnosis GE Healthcare's Medi-Physics division received FDA approval for DaTscan (ioflupane I-123), a diagnostic im…
# FDA Approves Alembic Pharmaceuticals' Generic Lamotrigine Alembic Pharmaceuticals Limited has received FDA approval for its generic lamotrigine oral formulation, expanding the c…
# FDA Approval Newswire Rising Pharmaceuticals received FDA approval for a new generic drug formulation (ANDA090431) on December 28, 2010, positioning the company to capture marke…
# FDA Approves Amneal Pharmaceuticals' Generic Oxymorphone Hydrochloride Amneal Pharmaceuticals of New York LLC received FDA approval for its generic oxymorphone hydrochloride ora…
GENUS LIFESCIENCES received U.S. approval on Oct. 20 for NDA200534, a drug application; this regulatory milestone positions the company to potentially expand its market footprint p…
Genus Lifesciences Inc. received FDA approval on October 20, 2010, for OxyCODONE HYDROCHLORIDE (NDA200535), a move expected to bolster the generic market for this critical analgesi…
# FDA Approves Strides Pharma's Generic Losartan Potassium Tablet Strides Pharma Science Limited received FDA approval for its generic losartan potassium 25 mg tablet, expanding t…
# FDA Approves Lupin Pharmaceuticals' Generic Losartan Potassium Lupin Pharmaceuticals, Inc. received FDA approval for its generic losartan potassium oral formulation (ANDA078232)…
Hikma Pharmaceuticals USA Inc. secured FDA approval to manufacture the generic form of Oxymorphone Hydrochloride, an oral analgesic, providing a cost-effective alternative to brand…
On July 30, 2010, Merz Pharmaceuticals, LLC received FDA approval for XEOMIN (incobotulinumtoxin A), signaling a new entrant in the botulinum toxin type A market that is poised to …
Knoa Pharma LLC secured FDA approval for its BUTRANS transdermal patch, expanding the market for long-acting opioid delivery systems in the chronic pain management sector.
Moments ago, ANI PHARMS announced FDA approval for its generic version of the unnamed substance, expected to broaden the company’s revenue streams and drive market share expansion …
Walgreens received FDA approval on June 2 for a generic topical acne treatment containing Adapalene, a move expected to intensify competition and price pressures within the dermato…